Indeed, dysregulation in sialyltransferase expression leads to an accumulation of sialylated glycans in breast cancer, which, similar to the PD-L1–mediated T cell exhaustion pathway, may promote immune evasion by activating the emerging Siglec immunoreceptors (21). This evidence concerns the gene CD274 and breast carcinoma.